bibliographic entry 12414299 [be/12414299]
https://w3id.org/oc/corpus/be/12414299

is a
content
  • Hanna, N. H, Kaiser, R, Sullivan, R. N, Aren, O. R, Ahn, M-J, Tiangco, B, … Kim, J. H. (2013). Lume-lung 2: A multicenter, randomized, double-blind, phase III study of nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after failure of first-line chemotherapy. ASCO Meeting Abstracts, 31(15_suppl), 8034.
references